Singapore became a Gavi donor in 2020 during the COVID-19 pandemic, contributing US$ 5 million to the Gavi COVAX AMC. In 2025, Singapore deepened its partnership with Gavi by pledging US$ 1 million towards Gavi’s 2026–2030 strategic period (Gavi 6.0). 

The commitment was announced at Gavi’s Global Summit: Health & Prosperity through Immunisation in Brussels, where Singapore’s Minister for Health, H.E. Ong Ye Kung, delivered a video message reaffirming Singapore’s support for Gavi and global vaccine equity. The pledge marks an important evolution in Singapore’s engagement with Gavi, from pandemic-specific support through COVAX to a contribution towards Gavi’s broader immunisation mission for the 2026–2030 period.  

Proceeds to Gavi 6.0 as of 30 June 2026†
Contributions to Gavi Board approved financing instruments

*Local currency

†Proceeds are the funds that Gavi receives from donor commitments, either through direct donor payments, funding raised in advance against future donor pledges through IFFIm, or AMC funds released by the World Bank.

Contributions and pledges per strategic period (US$ millions)

Hover over the bar chart above to view the data

Direct Contributions (including Matching Fund)

Non-US$ contributions are converted to US$ as follows:

  • Before Gavi 6.0 (2000–2025): exchange rate on date of receipt; where hedged (2014–2025), the hedge rate applies instead.
  • Gavi 6.0 (2026 onward, received & future contributions and Matching Fund Pledges): Bloomberg replenishment rate, 16:00 London time, 25 June 2025.

IFFIm Contributions

Non-US$ contributions are converted to US$ as follows:

  • Received Contributions: rate confirmed by the World Bank's International Bank for Reconstruction and Development (IBRD).
  • Future, signed contribution agreements: exchange rate at time of signing.
  • Future, unsigned contribution agreements: Bloomberg replenishment rate, 16:00 London time, 25 June 2025.

 

All donors